The Journal of Clinical and Aesthetic Dermatology

Matrix Medical Communications
  • 0.0 (0)
  • MEDICINE

JCAD's audio platform provides interviews with leading experts in the dermatology field. 

  1. James Del Rosso, DO: JCAD February 2026 Issue Highlights

    FEB 26

    James Del Rosso, DO: JCAD February 2026 Issue Highlights

    Send a text James Del Rosso, DO, the Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the February 2026 issue of JCAD.

    24 min
  2. Amy McMichael, MD: Eight-Week Outcomes With Deuruxolitinib in Alopecia Areata

    FEB 19

    Amy McMichael, MD: Eight-Week Outcomes With Deuruxolitinib in Alopecia Areata

    Send a text Amy McMichael, MD, a clinical professor and chair of the Department of Dermatology at Wake Forest School of Medicine, discusses deuruxolitinib for patients with alopecia areata. She highlights its 8-week efficacy compared to placebo in clinical trials. The medication provided significant improvement in hair regrowth at the 8-mg dose, with minimal adverse events. She emphasized the need to perform standard baseline and intermittent lab tests in patients, similar to other Janus kinase inhibitors.

    6 min
  3. James Del Rosso, DO, and David Cotter, MD, PhD: The Use of Gene-Expression Profile Testing for Effective Atopic Dermatitis Treatment

    FEB 19

    James Del Rosso, DO, and David Cotter, MD, PhD: The Use of Gene-Expression Profile Testing for Effective Atopic Dermatitis Treatment

    Send a text James Del Rosso, DO, and David Cotter, MD, PhD, discuss using gene expression profile testing, such as the AdvanceAD-Tx test, to provide effective treatment for patients with atopic dermatitis. AdvanceAD-Tx allows clinicians to match therapy based on patients’ immune profiles using molecular testing. Drs. Del Rosso and Cotter also review the benefits of using the test not only at baseline, but also throughout treatment in order to tailor their atopic dermatitis therapy and avoid constantly cycling through treatments.

    19 min
  4. Graham Litchman, DO, MS: Understanding Long-Term Treatment Success in a Patient With Psoriasis

    FEB 17

    Graham Litchman, DO, MS: Understanding Long-Term Treatment Success in a Patient With Psoriasis

    Send a text Graham Litchman, DO, MS, a board-certified dermatologist at Vivida Dermatology in Las Vegas, Nevada, discusses a patient case involving a 54-year-old female patient with psoriasis who did not respond well to conventional treatments or systemic steroids. Dr. Lichtman introduced her to risankizumab (Skyrizi), explaining its mechanism of action, adverse events, and dosing schedule. The patient experienced significant improvement by the 3-month mark, with most plaques disappearing. After 1 year of treatment, the patient had only a small area of plaques.

    9 min
  5. James Del Rosso, DO: JCAD January 2026 Issue Highlights

    JAN 30

    James Del Rosso, DO: JCAD January 2026 Issue Highlights

    Send a text James Del Rosso, DO, the Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the January 2026 issue of JCAD.

    23 min
  6. Aaron Farberg, MD: Real-World Experiences in Alopecia Areata Treatment

    JAN 22

    Aaron Farberg, MD: Real-World Experiences in Alopecia Areata Treatment

    Send a text Dr. Aaron Farberg, a board-certified dermatologist and founder of Bear Dermatology in Dallas, Texas, discusses the evolving treatment landscape for alopecia areata with a focus on Janus kinase inhibitors and how he has used this type of treatment in his practice.

    5 min
  7. Arash Mostaghimi, MD, MPH, FAAD: Considerations for the Use of Deuruxolitinib in Patients with Alopecia Areata

    12/02/2025

    Arash Mostaghimi, MD, MPH, FAAD: Considerations for the Use of Deuruxolitinib in Patients with Alopecia Areata

    Send a text Dr. Mostaghimi discusses the speed and depth of efficacy of deuruxolitinib for providing hair regrowth in patients with severe alopecia areata.

    5 min
  8. James Del Rosso, DO: JCAD November 2025 Issue Highlights

    11/20/2025

    James Del Rosso, DO: JCAD November 2025 Issue Highlights

    Send a text Dr. Del Rosso, Clinical Editor-in-Chief of the Journal of Clinical and Aesthetic Dermatology, discusses highlights from new research published in the November 2025 issue of JCAD.

    20 min
See All (52)

About

JCAD's audio platform provides interviews with leading experts in the dermatology field. 

Information